Edesa Biotech, Inc.EDSANASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank13
3Y CAGR-17.9%
5Y CAGR-3.1%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-17.9%/yr
vs +16.0%/yr prior
5Y CAGR
-3.1%/yr
Recent deceleration
Acceleration
-33.9pp
Decelerating
Percentile
P13
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $101623.00 | -14.8% |
| 2025 | $119273.00 | -35.9% |
| 2024 | $186049.00 | +1.4% |
| 2023 | $183471.00 | +55.2% |
| 2022 | $118188.00 | -0.5% |
| 2021 | $118788.00 | +574.9% |
| 2020 | $17601.00 | -82.6% |
| 2019 | $101286.00 | -77.3% |
| 2018 | $445320.00 | -16.7% |
| 2017 | $534453.00 | - |